TrumpRx vs GoodRx: which is actually cheaper for your drug in 2026?

What TrumpRx is

TrumpRx is a federal government website at trumprx.gov that works like a price-comparison directory, not a pharmacy and not an insurance plan. You cannot buy a drug on the site itself. You search for a medication, and TrumpRx shows you a cash discount and then routes you to a manufacturer's direct-to-consumer program or a partner pharmacy to complete the purchase. It launched February 5, 2026 with about 40 brand-name medicines from five manufacturers (AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, per the White House launch fact sheet¹; CBS News counted 43⁶). The brand prices use a most-favored-nation model, meaning the U.S. cash price is benchmarked to roughly the lowest price the same brand sells for in comparable developed countries. On May 18, 2026 the site expanded well beyond brands: it added more than 600 generic medications by aggregating prices from Amazon Pharmacy, Mark Cuban Cost Plus Drugs, and GoodRx². So the old shorthand that TrumpRx is brand-only is now out of date. One thing to keep in mind: for generics, the TrumpRx price is a ZIP-located lowest price pulled from those partners, not a fixed federal rate, so it changes by location and over time.

What GoodRx is and how it differs

GoodRx is a private discount-card company. It negotiates coupon prices with pharmacy benefit managers and shows you a price you can claim at the pharmacy counter, usually for free. The key difference from TrumpRx is the source of the price. TrumpRx surfaces manufacturer most-favored-nation deals and partner-pharmacy prices through a government portal; GoodRx surfaces pharmacy-network coupon prices that vary by pharmacy, ZIP code, and date. That variability matters: a GoodRx price you see today may differ tomorrow or a mile away, which is why every GoodRx number in this article is labeled representative and worth verifying at point of sale. There is also a relationship worth knowing about. GoodRx is not a pure competitor of TrumpRx. In its own words it is a key integration partner that powers the pricing for leading brand medications on TrumpRx, and at launch it was the integrated pricing source for Pfizer, including more than 30 of Pfizer's brand medicines⁴. We cover what that means for trust in the wedge section below.

Is TrumpRx cheaper? The by-drug answer

Short answer: usually not, with a few exceptions. We price-checked 16 widely used drugs on June 1, 2026 across TrumpRx, GoodRx, SingleCare, Cost Plus Drugs, and manufacturer-direct programs. TrumpRx was the single cheapest verified cash option on only one of them, Januvia, at $84.57 a month. On all seven common generics we checked (atorvastatin, metformin, lisinopril, amlodipine, sertraline, omeprazole, and levothyroxine), Mark Cuban Cost Plus Drugs was the cheapest, at roughly $5.20 to $5.93 for a 30-day supply with shipping included. On the two generics where we could read TrumpRx's own number, it tracked just above Cost Plus (for example, atorvastatin at $6.10 on TrumpRx versus $5.46 on Cost Plus), which makes sense because TrumpRx aggregates Cost Plus among its partners. This matches independent reporting: STAT News found at least 18 of TrumpRx's launch drugs had cheaper generic equivalents elsewhere³, and KFF found at least three-quarters of TrumpRx drugs that have a generic equivalent were cheaper via GoodRx or Cost Plus⁵. The honest takeaway is that TrumpRx is a real option worth checking, but it is rarely the floor. Always compare it against Cost Plus for generics and against the manufacturer's own self-pay program for brand-name and GLP-1 drugs.

The full audit: 16 drugs, 5 sources, June 1, 2026

Flat published prices (Cost Plus, manufacturer self-pay, TrumpRx brand) are quoted directly and dated. GoodRx and SingleCare are coupon prices that vary by pharmacy and ZIP, shown as representative and to be verified at the counter. "Not checked" means we did not stand behind a specific figure this pass rather than guess.

Which GLP-1 is cheapest

For GLP-1 drugs, the cheapest cash price almost always comes straight from the manufacturer, not from TrumpRx or a coupon. Here is the important distinction first: the widely shared $149 a month TrumpRx figure for Ozempic and Wegovy is for the oral pill versions, not the injectable pens most people picture. And on that oral pill, TrumpRx does not beat the manufacturer; it matches it, because NovoCare also sells the pill at $149 a month⁸. For the Wegovy and Ozempic injectable pens, the cheapest fixed cash route is NovoCare self-pay: $199 a month as an introductory price for the first two fills through June 30, 2026, then $349 a month for standard doses (higher for the top doses). For tirzepatide, LillyDirect single-dose vials of Zepbound are the clear cheapest cash path at $299 to $449 a month depending on dose⁹, far below coupon prices that hover near the roughly $1,000 list. Mounjaro has no manufacturer cash self-pay vial program, so the cheapest tirzepatide cash route is the same-molecule Zepbound vials from LillyDirect. Neither Zepbound nor Mounjaro appeared on TrumpRx as of June 1, 2026, but that costs patients nothing because LillyDirect already sets the floor. Bottom line for GLP-1s: check the manufacturer's own self-pay program first. For safety, use only FDA-approved products from state-licensed pharmacies and avoid gray-market or compounded peptides¹³.

Why some drugs are cheaper elsewhere (the wedge)

There is a structural reason TrumpRx is often not the cheapest, and it comes down to who supplies the prices. GoodRx, in its own words, is a key integration partner that powers the pricing for leading brand medications on TrumpRx, and at launch it was the integrated pricing source for over 30 of Pfizer's brand medicines⁴. A GoodRx spokesperson told STAT the company is also working with the Department of Health and Human Services to integrate its pricing feed so TrumpRx shows current prices. That means the same company supplying TrumpRx's brand prices is often the one whose own coupons, or a Cost Plus generic, undercut them. A company in that position has little incentive to advertise the gap, which is why it took independent analyses from STAT and KFF to surface it. The other reason is simpler: TrumpRx's brand deals price the brand-name drug, but for many conditions an FDA-approved generic exists at a fraction of the cost. STAT documented cases like pantoprazole (Protonix), where the brand ran about $200 for a 30-pack on TrumpRx while the Cost Plus generic was around $6³. The lesson is not that TrumpRx is a scam; it is that a single source, even a government one, is not automatically the lowest. Comparing brand against generic, and the directory price against the manufacturer's own price, is where the real savings hide.

The deductible question

Here is the single most important caveat, and the one most people miss. When you pay a cash or coupon price, whether from TrumpRx, GoodRx, or Cost Plus, instead of running the prescription through your insurance, that money generally does not count toward your insurance deductible or your annual out-of-pocket maximum. Your deductible is the amount you owe for covered services before your plan starts paying, and your out-of-pocket maximum is the most you pay in a year before the plan covers 100 percent of covered benefits (definitions from HealthCare.gov)¹¹¹². So if you are insured, have not yet met your deductible, and expect significant medical spending later in the year, paying cash for a cheaper sticker price can leave you worse off across the full plan year. This is exactly the trade-off CBS News and KFF flagged about TrumpRx⁵. The cheapest price at the counter is not always the cheapest price for your year.

Who qualifies and what the limits are

TrumpRx pricing is cash-pay only. The discounts are for patients buying out of pocket, and you generally cannot stack them with insurance; for many offers you must attest that you are paying cash, not using insurance, and will not seek reimbursement. You need a valid prescription, but there is no income test to use the published cash prices. The people who benefit most are the uninsured, the underinsured, and anyone whose plan does not cover a given drug or who has a high deductible they will not meet. If you are well insured, your copay may still be lower than the cash price, so compare both. Separately from these cash prices, manufacturers run copay savings cards (for example, NovoCare's Wegovy card brings the cost to as little as $25 for some commercially insured patients), but those cards are commercial-insurance-only and are barred by law for anyone on Medicare, Medicaid, TRICARE, VA, or Department of Defense coverage. For low-income and uninsured patients, manufacturers also run need-based Patient Assistance Programs that are separate from copay cards. We did not verify 2026 income thresholds for those programs, so check the manufacturer site directly.

The bottom line: how to actually get the lowest legitimate price

Do not assume any single source is the cheapest, including a government one. Work the comparison in this order.

1. Do the deductible math first. If you are insured, have not met your deductible, and expect big medical bills this year, running the prescription through insurance may beat a cheaper cash price over the full year. If you are uninsured or will not hit your deductible, cash and coupon prices are fair game.
2. Ask whether an FDA-approved generic exists. Generics are where flat-price pharmacies save the most. This is a cost question, not a recommendation to switch drugs.
3. For generics, price-check Cost Plus Drugs against your copay. In our June 2026 audit, Cost Plus was cheapest on all seven generics, roughly $5.20 to $5.93 for a 30-day supply, shipping included.
4. For brand-name and GLP-1 drugs, compare TrumpRx against the manufacturer's own self-pay program (NovoCare, LillyDirect). For GLP-1s the manufacturer is usually the cheapest cash route, and TrumpRx often mirrors rather than beats it.
5. Check for a manufacturer copay card if you have commercial insurance. If you are on Medicare, Medicaid, TRICARE, VA, or DOD coverage you are barred from copay cards; ask instead about the manufacturer's need-based Patient Assistance Program.
6. Ask the pharmacist to run every option for this fill and confirm it is the FDA-approved product from a state-licensed pharmacy. The pharmacist is your final neutral check on both price and legitimacy.

Frequently asked questions

Sources

1. White House Fact Sheet: President Trump Launches TrumpRx.gov: launch date, 40 branded drugs from 5 manufacturers, most-favored-nation model.
2. White House Fact Sheet: Expansion of TrumpRx.gov to everyday medicines: May 18, 2026 expansion adding 600+ generics via Amazon Pharmacy, Cost Plus, and GoodRx.
3. STAT News: TrumpRx undercut by cheaper generics: at least 18 launch drugs had cheaper generic equivalents; Protonix example.
4. STAT News: What to know about TrumpRx: GoodRx as key integration partner powering brand pricing; 30+ Pfizer brands.
5. KFF: TrumpRx, What's the Value for Customers?: three-quarters of TrumpRx drugs with a generic equivalent cheaper elsewhere; deductible caveat.
6. CBS News: TrumpRx drug website discount details: cash-pay only, no insurance stacking, does not count toward deductible; 43-drug count.
7. Mark Cuban Cost Plus Drugs: atorvastatin 20mg: flat published generic price ($5.46/30, shipping included).
8. NovoCare / PR Newswire: Novo Nordisk $199 self-pay offer: injectable self-pay floor; $149 oral pill price.
9. Eli Lilly: Zepbound single-dose vial pricing: LillyDirect vial self-pay ($299/$399/$449 by dose).
10. BMS / Pfizer: brand Eliquis via Cost Plus Drugs: brand Eliquis flat $345 for a 30-day supply.
11. HealthCare.gov Glossary: Deductible
12. HealthCare.gov Glossary: Out-of-pocket maximum
13. FDA: Concerns with unapproved GLP-1 drugs: safety basis for FDA-path-only GLP-1 channels.
14. AJMC: Two Months Later, Success of TrumpRx Is Mixed: real-world availability and savings have been mixed.